The National Pharmaceutical Pricing Authority (NPPA) on June 25, 2024, issued a notification regarding the fixation of the retail price of Dolutegravir Sodium eq. to 50 mg of Dolutegravir + Emtricitabine 200 mg + Tenofovir alafenamide 25 mg (eq. to 28 mg of Tenofovir alafenamide fumarate).
The following has been stated: -
•For each Film-coated tablet contains: Dolutegravir Sodium eq. to 50 mg of Dolutegravir + Emtricitabine 200 mg + Tenofovir alafenamide 25 mg (eq. to 28 mg of Tenofovir alafenamide fumarate) for M/s. APL Healthcare Ltd. (Manufacturer) & M/s Aurobindo Pharma Ltd. (Marketer) (F. No. 3986) the retail price is Rs.121.21.
The detailed notification is given in the document attached below.
[Notification No. 19(3986)/2024/DP/NPPA/DIV.II]
